Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

0d954e208dcd6692555b9cb7.14aoKRwiZXNFXItCmITFYIr8ALcKR-UbOj9PGT_UUDE.mMLNdlFWOipzLrMkzdWtKvy9LYRvA79-eRICdn6VJAG6toVOVlIRRxRuwg~3f3d8161fda60b87d3616a5d9422980f
12/25/12 Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15 MT
06/25/06 Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating MT
25/24/25 The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18 MT
25/24/25 Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18 MT
15/24/15 Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating MT
29/24/29 Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating MT
18/23/18 Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating MT
31/23/31 Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating MT
30/23/30 Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22 MT
01/23/01 Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target MT
01/23/01 Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating MT
28/23/28 Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating MT
18/23/18 BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50 MT
07/23/07 Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating MT
09/23/09 BofA Securities Upgrades Core Laboratories to Neutral From Underperform MT
07/22/07 Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24 MT
26/22/26 Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target MT
02/22/02 Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating MT
01/22/01 Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating MT
15/22/15 BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating MT
13/22/13 Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating MT
13/22/13 Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating MT
02/22/02 Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating MT
18/22/18 Piper Sandler Downgrades Core Laboratories to Underweight From Neutral MT
11/22/11 Morgan Stanley Adjusts Core Laboratories' Price Target to $35 from $30, Keeps Equalweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+6.47%
+13.69%
+34.73%
- - -
+43.9%
- - +74.85%
+47.76%
Average +36.90%
Weighted average by Cap. +16.24%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
11.02USD
Average target price
16.33USD
Spread / Average Target
+48.22%
High Price Target
22.00USD
Spread / Highest target
+99.64%
Low Price Target
12.00USD
Spread / Lowest Target
+8.89%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Citigroup
Zephirin Group
Zephirin
Stifel Nicolaus
Piper Sandler
Morningstar
BofA Securities
Morgan Stanley
Cowen
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
11.02USD
Average target price
16.33USD
Spread / Average Target
+48.22%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLB Stock
  4. HJ1 Stock
  5. Consensus Core Laboratories Inc.